1An empirical study on influencing factors of capital investment in cooperative innovation in China's pharmaceutical manufacturing industryFAN Ming-jie, QU Feng-hong1345-13492Analysis and suggestions on the patent layout status of traditional Chinese medicine in Guangdong-Hong Kong-Macao Greater Bay AreaCHEN Chuang-rong, ZHANG Geng-yu, HONG Hai-du, XIE Zhi-rong, CAI Xiao-yan1350-13583Reflections on real world research under the evidence system of"three combinations"registration and evaluation of new traditional Chinese medicineAN Na, HAN Ling, CHEN Ping-yan1359-13634Pharmaceutical considerations on the development of generic drugs of nebulizer suspensionYANG Wen-zhi, NING Li-li1364-13665Progress in research on cardiovascular protective mechanism of glucagon-like peptide-1 receptor agonistsCUI Xin, WEI Xiao-tong, YAN Wen-hui, CHEN Li-na1367-13716Research progress of joint cavity injection drug delivery systems for the treatment of osteoarthritisXU Yi-lin, LIN Peng, CHEN Xi, ZHOU Li-li, ZOU Man-shu, MO Mei-xia, XIA Xin-hua1372-13797Research progress in oral delivery technology of therapeutic peptidesHUANG Kan, SUN Min-jie1380-13868Research and development strategy of vaccine for emergent infectious diseases: Taking the COVID-19 pneumonia as an exampleYAN Shu, YANG Xiao-yi, YANG Yu-sheng, CHEN Juan, LU Yan, OUYANG Zhao-lian1387-13949Autoimmune diseases and vaccination against coronavirus disease 2019ZHU Yue-zhen, LI Xue, ZHONG Xue1395-140110A benchmarking analysis for improvement of whole process management of investigator initiated trialsWU Rong, LU Ting-ting, HU Dan, ZHU Zhu1402-140611Exploration and practice of establishing multi-level and all-round three-dimensional quality control model in clinical trial institutionsLU Ming-ying, LIU Yu, ZHANG Tian-xiang, ZHANG Cai-xia, YI Qiu-yue1407-141012Preparation process optimization, characterization and dissolution characteristics of dihydromyricetin nanoparticlesLI Zi-rui, LU Hui-ling, XIAO Yi-fei, LI Ya1411-141913Synthesis and antioxidant activity of tectorigenin derivativesCHEN Shuai, LUO Sen, TAN Zheng-huai, LIU Qi, TANG Yi-na, ZHANG Lei, ZHU Min, WANG Jia, YUAN Chong-jun1420-142514Embryo-fetal toxicity and concomitant toxicokinetic assessment of PDQ in SD ratsSHEN Jiao, LU Bing-bing, LU Fan, GAO Qing-fa, YUE Peng, LIU Jing1426-143215Synthesis of piperlongumine derivatives and their inhibitory effects on doxorubicin-resistant strain of human K562 leukemiaDING Ze-dan, TIAN Jian-hui, TAN Shu-dan, WANG Chuan, ZOU Yu1433-144016Network Meta analysis and pharmacoeconomic evaluation of three drugs in the treatment of acute ischemic strokeJING Jun-kai, SUN Li-hua1441-1448 